Another meta-analysis of 21 studies (9557 patients) that compared systemic safety of anti-VEGF treatment in AMD, DME and retinal vein occlusion found no association between anti-VEGF and increased mortality or vascular events [43]. Here, VEGFA is linked to retinal vein occlusion.